Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

about

Outcome and prognostic factors in single brain metastases from small-cell lung cancer.

P2860

Q47994199-CF86390B-EC66-4299-8378-AED3C4AC3375

P2860

Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

Item

http://www.wikidata.org/entity/Q36385818

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Outcome and prognostic factors ...... with whole brain radiotherapy.

@ast

Outcome and prognostic factors ...... with whole brain radiotherapy.

@en

type

Item

label

Outcome and prognostic factors ...... with whole brain radiotherapy.

@ast

Outcome and prognostic factors ...... with whole brain radiotherapy.

@en

prefLabel

Outcome and prognostic factors ...... with whole brain radiotherapy.

@ast

Outcome and prognostic factors ...... with whole brain radiotherapy.

@en

P1476

Outcome and prognostic factors ...... with whole brain radiotherapy.

@en

P2093

Claus Peter Heußel

http://www.w3.org/2001/XMLSchema#string

Felix Herth

http://www.w3.org/2001/XMLSchema#string

Juliane Hoerner-Rieber

http://www.w3.org/2001/XMLSchema#string

Jutta Kappes

http://www.w3.org/2001/XMLSchema#string

Martin Steins

http://www.w3.org/2001/XMLSchema#string

Michael Thomas

http://www.w3.org/2001/XMLSchema#string

Nils Opfermann

http://www.w3.org/2001/XMLSchema#string

Sebastian Adeberg

http://www.w3.org/2001/XMLSchema#string

Stefan Rieken

http://www.w3.org/2001/XMLSchema#string

P2860

Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases

Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.

Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. a multicentre phase II study.

Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Prophylactic cranial irradiation in extensive small-cell lung cancer.

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.

P2888

s11060-017-2510-0

P304

205-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-017-2510-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28560661

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

about

P2860

P2860

Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921